United States· US:22840-3414_36ac4a35-6d79-a249-e063-6294a90a0b70
Olive Pollen
A medicinal product containing olea europaea pollen, registered in United States by Greer Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLEA EUROPAEA POLLEN
- Manufacturer
- Greer Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11228403414210 mL in 1 VIAL, MULTI-DOSE (22840-3414-2)
- ndc11228403414450 mL in 1 VIAL, MULTI-DOSE (22840-3414-4)
- ndc1122840-3414-2
- ndc1122840-3414-4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe48835a-f5a3-4b63-a758-00545c2f1dd3 GET /v1/drugs/fe48835a-f5a3-4b63-a758-00545c2f1dd3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS",
"source": "ndc",
"strength": ".1",
"substance": "OLEA EUROPAEA POLLEN",
"productndc": "22840-3414",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "BLA101833",
"marketing_category": "BLA"
}See everything about olea europaea pollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.